Exacerbated activation of glutamate receptor-coupled calcium channels and subsequent increase in intracellular calcium ([Ca 2 þ ] i ) are established hallmarks of neuronal cell death in acute and chronic neurological diseases. Here we show that pathological [Ca 2 þ ] i deregulation occurring after glutamate receptor stimulation is effectively modulated by small conductance calcium-activated potassium (K Ca 2) channels. We found that neuronal excitotoxicity was associated with a rapid downregulation of K Ca 2.2 channels within 3 h after the onset of glutamate exposure. Activation of K Ca 2 channels preserved K Ca 2 expression and significantly reduced pathological increases in [Ca 2 þ ] i providing robust neuroprotection in vitro and in vivo. These data suggest a critical role for K Ca 2 channels in excitotoxic neuronal cell death and propose their activation as potential therapeutic strategy for the treatment of acute and chronic neurodegenerative disorders.
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Exacerbated activation of glutamate receptor-coupled calcium channels and subsequent increase in intracellular calcium ([Ca 2 þ ] i ) are established hallmarks of neuronal cell death in acute and chronic neurological diseases. Here we show that pathological [Ca 2 þ ] i deregulation occurring after glutamate receptor stimulation is effectively modulated by small conductance calcium-activated potassium (K Ca 2) channels. We found that neuronal excitotoxicity was associated with a rapid downregulation of K Ca 2.2 channels within 3 h after the onset of glutamate exposure. Activation of K Ca 2 channels preserved K Ca 2 expression and significantly reduced pathological increases in [Ca 2 þ ] i providing robust neuroprotection in vitro and in vivo. These data suggest a critical role for K Ca 2 channels in excitotoxic neuronal cell death and propose their activation as potential therapeutic strategy for the treatment of acute and chronic neurodegenerative disorders. Excessive release of glutamate and uncontrolled neuronal excitations lead to progressive neuronal death following cerebral ischemia. In particular, glutamate-induced stimulation of a-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid and N-methyl-D-aspartate (NMDA) receptors mediates toxic increases in intracellular calcium concentrations ([Ca 2 þ ] i ). In neurons, disrupted intracellular calcium homeostasis disturbs multiple metabolic processes thereby promoting progressive cell death. [1] [2] [3] Consequently, inhibition of NMDA receptors has been extensively investigated in experimental and clinical stroke studies. For example, studies on NMDA receptor antagonists such as dizocilpine (MK-801) or memantine revealed neuroprotective effects against ischemia-induced neuronal death in vitro and ischemic brain damage in vivo, 4, 5 promoting disturbed [Ca 2 þ ] i as a promising therapeutic target. However, inhibitors of NMDA receptors largely failed in clinical studies 6 and, therefore, novel strategies controlling [Ca 2 þ ] i homeostasis are warranted for the development of effective therapies of neurological disorders associated with excessive NMDA receptor stimulation.
It has been suggested that small-conductance calciumactivated potassium (KCNN/SK/K Ca 2) channels may control membrane excitability through attenuated NMDA receptor activity. 7, 8 Figure S1B) . This finding is consistent with other reports that founds that TTX does not block DCD formation 1 and also does not prevent the delayed cell death.
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Single-cell fluorescence imaging further revealed that pretreatment of neurons with NS309, an activator of K Ca 2 channels, 12 prevented increases in [Ca 2 þ ] i , and significantly reduced DCD (Figure 1 Figure S1A) .
In contrast to the findings with the K Ca 2 activator NS309, pharmacological inhibition of K Ca 2 channels with NS8593 further increased the glutamate-induced increases in [Ca 2 þ ] i levels in the DCD phase (Figures 1a and b) . As NS8593 is a negative modulator for all K Ca 2 channels, 10 we used the highly specific K Ca 2.2 channel blocker apamin. In line with findings obtained with NS8593, apamin also promoted a further increase in [Ca 2 þ ] i compared with the glutamate challenge alone (Figure 1c) . Moreover, pre-incubation with apamin reduced the effect of NS309 on [Ca 2 þ ] i (Figure 1d ).
Previous studies established NS309 as a potent activator of recombinant K Ca 2 channels that induces an increase of the I AHP in hippocampal brain slices. 12 Here we tested the effect of NS309 (50 mM) on I AHP in CA1 neurons from 17-to 21-day-old mice. Before NS309 application, the depolarization step induced a characteristic I AHP . NS309 induced an increase of IAHP in all cells tested (six of six cells; Supplementary Figure S2 ). That was detectable even if the activator was removed from the bath (Supplementary Figure S2) .
To further strengthen the direct action of K Ca 2 channels on calcium signaling, we investigated whether other potassium channels might affect calcium homeostasis. To this end, we applied diazoxide, a specific activator of K ATP channels. Pretreatment and also post-treatment with diazoxide did not affect glutamate-induced DCD, suggesting that K ATP channels do not have a direct effect on DCD signaling. In addition, inhibition of K ATP channels with glibenclamide did not significantly alter the DCD (Supplementary Figure S3) (Figure 1e ). In contrast, when primary cortical neurons were subjected to toxic doses of glutamate in the presence of the K Ca 2.2 channel blocker apamin, neuronal cells were not rescued (Figure 1e ). Further, apamin also attenuated NS309-induced neuronal survival indicating that neuroprotection by NS309 was mediated through K Ca 2.2 channel activation ( Figure 1e ). Although NS8593 (50 mM) in combination with the glutamate challenge resulted in a further increase in DCD mean values compared with DCD induced by glutamate alone, NS8593 failed to show a further induction of apoptotic markers, such as caspase 3 activation (Supplementary Figure S3) . As a positive control for a complete induction of cellular death we used ionomycin at different concentrations ( Figure 1e ). Notably, NS309 failed to promote cellular survival against glutamate toxicity when K Ca 2.2 channels were downregulated by siRNA, confirming the particular role of this subtype as previously demonstrated by pharmacological compounds (Supplementary Figure S4) . Overall, these findings strongly suggest that K Ca 2 channel activity was critical for the maintenance of intracellular Ca Figure S6D) . Moreover, MTT analysis revealed that pretreatment with NS309 rescued primary neurons from NMDAinduced neuronal death, suggesting that K Ca 2 channels affected NMDA receptor activity and attenuated NMDAmediated excitotoxicity (Supplementary Figure S6E) . Glutamate neurotoxicity is associated with reduced K Ca 2 channel protein levels. To gain further insight into the relation between glutamate toxicity and K Ca 2 channelmediated [Ca 2 þ ] i regulation, we next investigated the expression levels of K Ca 2 channels after the glutamate challenge. Glutamate reduced the protein levels of K Ca 2.2 channels in a time-dependent manner (Figure 4a ). These results suggested that the observed DCD after glutamate receptor stimulation and the failure of NS309 to rescue [Ca 2 þ ] i levels when applied with delay was at least in part attributed to K Ca 2 channel degradation. In fact, the K Ca 2 channel activator NS309 prevented the glutamate-induced decrease in K Ca 2.2 channel expression (Figure 4b ) and NS309 protected neurons against glutamate toxicity when applied up to 3 h after the onset of glutamate challenge, which was perfectly in line with the observed protein expression levels of K Ca 2.2 channels (Figure 4c) Figure S7B) . This was potentiated in cells in which calpain activity was blocked, suggesting that Ca 2 þ -dependent activation of calpains negatively controls K Ca 2.2 channel protein levels.
Analysis of mRNA levels of K Ca 2 channel subtypes revealed that cortical neurons express all K Ca 2 subtypes: K Ca 2.1, K Ca 2.2 and K Ca 2.3 (Figures 4d and e) . The K Ca 2.3 (Figures 5a and b) . Non-treated animals showed extensive ischemic injury, whereas significant protection was observed in NS309-treated mice (Figure 5a) . Histomorphometrical analysis demonstrated that a single dose of NS309 (2 mg/kg) reduced the infarct volume to 45±4 mm 3 compared with the vehicle-treated controls (69 ± 7 mm 2 ; mean ± S.E.M.; Figure 5b ). The lower dose of NS309 (0.2 mg/kg) did not reduce the infarct volume compared to the controls. NS309-treated mice (2 mg/kg) exhibited fast and extensive recovery with improved neurological function score 14 compared with controls as determined 24 h after MCAo (Figure 5c ).
Discussion
In this study, we identified K Ca 2 channels as a promising target to preserve [Ca 2 þ ] i homeostasis by counteracting glutamate-and NMDA-induced [Ca 2 þ ] i deregulation and neurotoxicity in vitro and reducing infarct development after cerebral ischemia in vivo. In neurons, glutamate triggers immediate increases in [Ca 2 þ ] i through activation of NMDA-receptors followed by sustained disturbances in the intracellular Ca 2 þ homeostasis. 10, 15 However, key regulators of intracellular Ca 2 þ homeostasis that may serve as targets to prevent such sustained glutamate toxicity in neurological diseases have not been identified.
In this study, the K Ca 2 activator NS309 significantly attenuated [Ca 2 þ ] i increase when applied before the onset of DCD, and partially contributed to [Ca 2 þ ] i recovery when applied after onset of glutamate-induced DCD. Further, we observed a close correlation of the neuroprotective potential of K Ca 2 channel activation and their expression levels. Notably, activation of the K Ca 2 channels preserved their expression and their protective potential after exposure to glutamate or NMDA. Previous reports suggested that reduced expression and functional loss of K Ca 2 channels were connected to hyperexcitability in neurodegenerative processes. 16, 17 The exact mechanism of such K Ca 2 channel inactivation associated with neurodegenerative processes has not been clarified so far. Our results now indicate that In the soma of CA1 hippocampal regions, single-channel measurements showed that L-type calcium channel and K Ca 2 channels are co-localised. 9 The contribution of voltage-dependent channels to the formation and maintenance of DCD is unlikely, as previous experiments using the L-type calcium channel blocker nitrendipine had little effect on the delayed Ca 2 þ overload once DCD had been established. 1 However, a more recent study showed the involvement of transient receptor potential and store-operated Ca 2 þ channels, as the respective inhibitors 2-aminoethoxydiphenyl borate and La 3 þ attenuated glutamate-induced DCD. 18 In bullfrog sympathetic neurons, Ca 2 þ -induced Ca 2 þ release activation prolongs Ca 2 þ transients and activates BK channels that are closely associated with N-type Ca 2 þ channels, ryanodine and K Ca 2 channels. 9 Ryanodine and IP3 receptors might also be involved in DCD regulatory processes, as application of ryanodine or caffeine was shown to inhibit glutamate-induced DCD. 18 Removing the extracellular Ca 2 þ by adding the extracellular Ca 2 þ chelators EDTA or EGTA resulted in maintenance of [Ca 2 þ ] i . Thus, activation of K Ca 2 appears to be highly efficient to block pathological Ca 2 þ influx from the extracellular space in the context of glutamate excitotoxicity.
Pharmacological blockage of SERCA pumps with thapsigargin or BHQ partially blocked the protective effect of NS309 on DCD. However, thapsigargin alone did not alter [Ca 2 þ ] i and did not further exacerbate DCD, arguing against a major contribution of intracellular store depletion for the observed glutamate-induced DCD. Our observation is in agreement with a report describing that thapsigargin did not increase mean onset time or incidence of DCD. 18 Overall, our findings propose that NS309-mediated K Ca 2 activation restores Ca 2 þ homeostasis by diminishing the Ca 2 þ entry from the extracellular pool but still requires functional intracellular Ca 2 þ stores for full effectiveness.
Another important finding was that NS309 preserved the expression of K Ca 2 channels in neurons exposed to glutamate. This suggests that glutamate-induced excitotoxicity is mediated by activation of NMDAR and concomitant disruption of counteractive mechanisms such as K Ca 2 channels that disappear after the excitotoxic stimulus. This observation may explain both, the lack of adaptation to glutamate receptor overstimulation, and the therapeutic time window observed for NS309. As shown in this study, NS309 mediated neuroprotection only when applied up to 3 h after the onset of [Ca 2 þ ] i deregulation. This is in agreement with the time window of the progressive decline in K Ca 2.2 channel expression levels upon glutamate damage. After exposure to glutamate for 5 h or more, neurons expressed less K Ca 2.2 channels and around this time point NS309 lost the neuroprotective potential. Apparently, such reduced K Ca 2.2 protein levels resulted in a failure to regulate neuronal excitability despite increased Ca 2 þ concentrations that usually enhance the activity of the channel. Thus, neurons undergoing delayed neuronal death after the glutamate challenge were continuously deprived of this important feedback mechanism of [Ca 2 þ ] i , therefore showing increased excitability and deregulated calcium homeostasis. These findings are in agreement with the direct correlation between the prevention of DCD and reduced K Ca 2.2 channel degradation. The mechanism of K Ca 2 channel regulation is still unclear but may result from Ca 2 þ -dependent protein degradation or enhanced internalization from the membrane, which might be dependent on calpain activation.
Brief application of the glutamate receptor agonist NMDA, on the contrary, increased K Ca 2.2 channel protein levels, which was further augmented by calpain inhibition. This suggests that activation of calcium-dependent proteases and/ or Ca 2 þ -dependent gene transcription may regulate K Ca 2.2 channel expression physiologically. Although Ca 2 þ -activated calpains may enhance K Ca 2.2 degradation, nuclear factor-k B (NF-kB) activity may enhance neuroprotective K Ca 2.2 expression. 19, 20 It has been shown that preserved transcriptional activity of NF-kB in neurons provides cerebroprotective effects in a variety of degenerative conditions after acute brain damage. 21, 22 Thus, in addition to direct pharmacological activation as achieved here with NS309, induction of K Ca 2 channel expression through enhanced NF-kB transcriptional activity may be an additional strategy to activate this system of intracellular Ca 2 þ regulation. The promising effects of K Ca 2 channel activation demonstrated in vitro are also relevant for ischemic neuronal death in vivo. Our data strongly suggest a therapeutic potential for K Ca 2 channel activators in paradigms of excitotoxic neuronal damage that contributes to infarct development after cerebral ischemia. In line with our findings, overexpression of K Ca 2 channels in the dentate gyrus attenuated kainic acid-induced hippocampal CA3 lesion, suggesting that K Ca 2 channels are a common motif of Ca 2 þ autoregulation at different glutamate receptors. 23 In vivo, the protective function of NS309 may be extended to non-neuronal cells, as NS309 can enhance ATPevoked membrane hyperpolarization, along with acute endothelial NO synthesis in isolated endothelial cells. In addition, NS309 was shown to augment the acetylcholineinduced vasodilatation in small-resistance arterioles that might improve the recovery of damaged tissue. 24 It is interesting to note that two FDA-approved drugs, namely, riluzole (used in the treatment of amyotrophic lateral sclerosis) and chlorzoxazone (used as central myorelaxant) 25 have been reported to enhance the activity of K Ca 2 channels, 26 suggesting a clinical relevance of the present findings on neuroprotection mediated by K Ca 2 channel activation in vitro and in vivo. For example, K Ca 2 channel activation may significantly contribute to the reported effects of the neuroprotectant riluzole, that is, that it inhibits the release of glutamate from nerve terminals, modulates NMDA receptors and reduces neuronal excitability. 27 In conclusion, our data suggest that activation of K Ca 2 channels promotes neuroprotection in vitro and in vivo by reducing glutamate-and NMDA-induced [Ca 2 þ ] i deregulation. K Ca 2 channels may, therefore, have a major role in the regulatory feedback loop that interrupts the glutamatetriggered neuronal hyperexcitability, progressive disturbance of Ca 2 þ homeostasis and excitotoxic neuronal death. Accordingly, K Ca 2 channels may serve as novel therapeutic targets to prevent intracellular Ca 2 þ overload under K Ca 2 channels regulate calcium homeostasis AM Dolga et al pathological conditions associated with glutamate-induced excitotoxicity.
Materials and Methods
Primary cortical neuron culture. Primary cortical neurons were plated at a density of 16 Â 10 3 cells/well (96 well plates) and 3 Â 10 5 cells/well (6 well plates) on polyethyleneimine pre-coated plates. Neurobasal medium supplemented with 5 mM HEPES, 1.2 mM glutamine, 2% (v/v) B27 supplement (20 ml/l) and gentamicin (0.1 mg/ml) was used as a culture medium. Neurons were treated with the K Ca 2 channel activator NS309, the K Ca 2 channel blocker NS8593 or apamin for the indicated time periods. On the basis of previous kinetic studies, NS309 was used at a concentration of 50 mM.
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Evaluation of cell viability. Neuronal viability was determined by the colorimetric MTT assay. The absorbance of each well was determined with an automated FLUOstar Optima reader (BMG Labtech, Offenburg, Germany) at 570 nm with a reference filter at 630 nm.
Calcium measurements in single neurons using calcium imaging. Primary cortical cells were incubated with 2 mM FURA-2 AM for 30 min at 371C in HEPES-ringer buffer. Drugs were diluted in HEPES-ringer buffer (20 mM glutamate, 500 mM NMDA, 50 mM NS309, 50 mM NS8593, 1 mM apamin, 25 mM MK801, 4 mM EDTA and 4 mM EGTA). Fluorescence intensities from single cells excited at the two wavelengths (F340 and F380) were recorded separately and combined (fluorescence ratio: r ¼ F340/F380) after background subtraction (fluorescence of a cell-free area).
Protein analysis. Primary cortical neurons were lysed in 20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% TritonX, 2.5 mM sodium pyrophosphate, 1 mM sodium orthovanadate, complete mini protease inhibitor cocktail tablet and phosphatase inhibitor cocktail 1 and 2. The membranes were incubated overnight with primary antibodies (1 : 3000; rabbit anti-K Ca 2.2 28 channel at 41C and afterwards with peroxidase-conjugated secondary antibodies (1 : 2500).
RT-PCR. Total RNA was extracted using the NucleoSpin RNA II kit (MachereyNagel GmbH & Co. KG, Düren, Germany). RT reactions were conducted in a thermo cycler with setting at 421C for 30 min. Amplifications using specific primers 29 by PCR were carried out for 27 or 30 cycles at various steps: (1) denaturing at 951C for 4 min; (2) 941C for 30 s; (3) annealing temperature (T m ) for 30 s, depending on the K Ca 2 isoform of interest; and (4) extension at 721C for 30 s. The final extension step was set to 721C for 5 min. The T m for K Ca 2.1 was 631C, 57,31C for K Ca 2.2 and 611C for K Ca 2.3.
Transient focal cerebral ischemia. All animal experiments were conducted according to the guidelines of Government of Upper Bavaria. Male C57BL/6 mice were subjected to 60 min transient MCAo by an intraluminal filament as previously described.
14 Mice were killed and brains were removed and frozen in powdered dry ice 24 h after reperfusion. Infarct volume was calculated by multiplying the infarct areas with the distance between sections. NS309 was administered 30 min before MCAo by intraperitoneal injection (100 ml per 20 g) at a concentration of 0.2 mg/kg and 2 mg/kg. Saline (0.9%) with 2% DMSO was used as vehicle.
Statistical analysis. All data are given as means ± S.D. For statistical comparisons between two groups, Student's t-test was used; multiple comparisons were performed by ANOVA followed by Scheffé's post hoc test. Calculations were performed with the Winstat standard statistical software package. For the MCAo experiments we have used the Mann-Whitney U-test for the analysis of differences between groups and also by ANOVA followed by Scheffé's or Tukey's as post hoc analysis. A statistically significant difference was assumed at Po0.05.
Other methods, including hippocampal slice preparation, patch-clamp recordings and data sanalysis were carried out as described in Andres et al. 29 , Li et al. 30 , Pedarzani et al. 31 and Landshamer et al. 32 Further details are provided in Supplementary Materials and Methods.
